Vitiligo treatment.
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury; D004247:DNA / Q000378:metabolism; D006801:Humans; D007666:Khellin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008107:Liver Diseases / Q000097:blood; D008544:Melanocytes / Q000187:drug effects / Q000528:radiation effects; D008730:Methoxsalen / Q000627:therapeutic use; D011701:PUVA Therapy; D012880:Skin Pigmentation; D014307:Trioxsalen / Q000627:therapeutic use; D014820:Vitiligo / Q000188:drug therapy* / Q000473:pathology
D007666:Khellin; D004247:DNA; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D008730:Methoxsalen; D014307:Trioxsalen